These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33863661)

  • 21. Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds.
    Tenekecioglu E; Sotomi Y; Torii R; Bourantas C; Miyazaki Y; Collet C; Crake T; Su S; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1313-1322. PubMed ID: 28365819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance.
    Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C
    Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Barkholt TØ; Neghabat O; Holck EN; Andreasen LN; Christiansen EH; Holm NR
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1075-1083. PubMed ID: 34967094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis.
    Ozaki Y; Garcia-Garcia HM; Hideo-Kajita A; Kuku KO; Haude M; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Dijkstra J; Waksman R
    Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):916-924. PubMed ID: 30590578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography Study.
    Ueki Y; Räber L; Otsuka T; Rai H; Losdat S; Windecker S; Garcia-Garcia HM; Landmesser U; Koolen J; Byrne R; Haude M; Joner M
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008657. PubMed ID: 32093514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.
    Ochijewicz D; Tomaniak M; Kołtowski L; Rdzanek A; Pietrasik A; Proniewska K; Partyka L; Dijsktra J; Huczek Z; Filipiak K; Opolski G; Kochman J
    Int J Cardiol; 2020 Aug; 312():27-32. PubMed ID: 32315682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III.
    Haude M; Ince H; Kische S; Abizaid A; Tölg R; Alves Lemos P; Van Mieghem NM; Verheye S; von Birgelen C; Christiansen EH; Barbato E; Garcia-Garcia HM; Waksman R;
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E502-E511. PubMed ID: 30079472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial.
    Garcia-Garcia HM; Haude M; Kuku K; Hideo-Kajita A; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Dijkstra J; Waksman R
    Int J Cardiol; 2018 Mar; 255():22-28. PubMed ID: 29292064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
    Haude M; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Lim ST; Escaned J; Garcia-Garcia HM; Waksman R
    Lancet; 2016 Jan; 387(10013):31-9. PubMed ID: 26470647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model.
    Waksman R; Zumstein P; Pritsch M; Wittchow E; Haude M; Lapointe-Corriveau C; Leclerc G; Joner M
    EuroIntervention; 2017 Jul; 13(4):440-449. PubMed ID: 28262623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Kim HO; Jiang B; Poon EKW; Thondapu V; Kim CJ; Kurihara O; Araki M; Nakajima A; Mamon C; Dijkstra J; Lee H; Ooi A; Barlis P; Jang IK
    Int J Cardiol; 2022 Jun; 357():1-7. PubMed ID: 35306029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
    Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
    EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Gutiérrez-Barrios A; Gheorghe LL; Camacho Freire S; Silva E; Gómez Menchero A; Francisco Jose MP; Cañadas Pruaño D; Martínez Capoccioni U; Gomez Lara J; Bretones Del Pino T; Calle Perez G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):E69-E77. PubMed ID: 33600069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
    Katagiri Y; Torii R; Takahashi K; Tenekecioglu E; Asano T; Chichareon P; Tomaniak M; Piek JJ; Wykrzykowska JJ; Bullett N; Ahmed N; Al-Lamee K; Al-Lamee R; Leclerc G; Kitslaar P; Dijkstra J; Reiber JHC; Poon EKW; Bourantas CV; Gijsen FJH; Serruys PW; Onuma Y
    EuroIntervention; 2020 Jun; 16(2):e141-e146. PubMed ID: 31289016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of local hemodynamics and plaque characteristics on neointimal response following bioresorbable scaffolds implantation in coronary bifurcations.
    Chu M; Gutiérrez-Chico JL; Li Y; Holck EN; Zhang S; Huang J; Li Z; Chen L; Christiansen EH; Dijkstra J; Holm NR; Tu S
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):241-249. PubMed ID: 31667662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold.
    Torii R; Tenekecioglu E; Katagiri Y; Chichareon P; Sotomi Y; Dijkstra J; Asano T; Modolo R; Takahashi K; Jonker H; van Geuns R; Onuma Y; Pekkan K; Bourantas CV; Serruys PW
    Eur Heart J Cardiovasc Imaging; 2020 Apr; 21(4):454-462. PubMed ID: 31215995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.